Resectable
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer (NCT03794544) | MedImmune LLC | 2019-03-08 |
| Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas (NCT03805022) | Institut Bergonié | 2019-02-14 |
Track Resectable automatically
Every clearance here is in the API, with alerts when new ones post.